Compliance & Legal
The Supreme Court's decision in Dobbs v. Jackson Women's Health Organization left a number of questions for healthcare stakeholders.
The execs sold advertising inventory the company didn't have, a jury found, then under-delivered on its advertising campaigns.
The Texas ruling was contradicted by Washington et al. v. FDA ruling, which ordered the FDA to keep mifepristone available.
HIMSS23
<p>Carium general counsel Matthew Fisher previews his HIMSS23 panel explaining the ways the Supreme Court's Dobbs v. Jackson Women's Health Organization decision affects healthcare data and access.</p>
While Texas decision eliminated constitutional grounds for coverage it doesn't mean insurers would stop the benefit, says legal expert.
AHIP President and CEO Matt Eyles says he fully expects an appeal.
The lawsuit criticizes PBM market consolidation, which has left the three largest PBMs in control of more than 75% of the market.
A number of healthcare organizations have defended the NSA and accused various legal challenges of trying to dismantle the law.
No reason was given for the request of voluntary dismissal.
The donations, according to the Department of Justice, were aimed at increasing Medicaid payments received by LRMC.